NDRA

ENDRA Life Sciences Inc. Common Stock

4.74

USD

-0.22

-4.45%

Oct 28, 15:58 UTC -4

Closed

Pre-Market

4.78

+0.04

+0.84%

ENDRA Life Sciences Inc. Common Stock (NDRA) Earnings

NDRA Earnings Reports

Positive Surprise Ratio

NDRA beat 19 of 30 last estimates.

63%

Next Report

Date of Next Report

Nov 12, 2026

Estimate for Q3 26 (Revenue/ EPS)

-$0.85

Implied change from Q2 26 (Revenue/ EPS)

-1516.67%

Implied change from Q3 25 (Revenue/ EPS)

-59.52%

ENDRA Life Sciences Inc. Common Stock earnings per share and revenue

On Aug 14, 2026, NDRA reported earnings of 0.06 USD per share (EPS) for Q2 26, beating the estimate of -0.85 USD, resulting in a 107.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.45% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.85 USD, with revenue projected to reach -- USD, implying an decrease of -1516.67% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Thermo Fisher Scientific, Inc.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$6.46

Actual

$6.68

Surprise

+3.29%

Intuitive Surgical Inc.

Report Date

Oct 20, 2026 For Q3 26

Estimate

$2.69

Actual

$3.00

Surprise

+11.29%

IQVIA Holdings Inc.

Report Date

Oct 27, 2026 For Q3 26

Estimate

$3.30

Actual

$3.34

Surprise

+0.97%

Glaukos Corporation

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.09

Actual

$0.47

Surprise

+611.98%

Axogen, Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.14

Actual

$0.21

Surprise

+47.06%

Integra LifeSciences Holdings

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.57

Actual

$0.59

Surprise

+3.04%

Beta Bionics, Inc. Common Stock

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.53

Actual

-$0.52

Surprise

+2.73%

OrthoPediatrics Corp. Common Stock

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.21

Actual

-$0.23

Surprise

-4.88%

ClearPoint Neuro, Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

-$0.32

Actual

-$0.24

Surprise

+25.30%

FAQ

What were ENDRA Life Sciences Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, ENDRA Life Sciences Inc. Common Stock reported EPS of $0.06, beating estimates by 107%, and revenue of $0.00, 0% as expectations.

How did the market react to ENDRA Life Sciences Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 0.45%, changed from $4.47 before the earnings release to $4.49 the day after.

When is ENDRA Life Sciences Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 12, 2026.

What are the forecasts for ENDRA Life Sciences Inc. Common Stock's next earnings report?

Based on 3 analysts, ENDRA Life Sciences Inc. Common Stock is expected to report EPS of -$0.85 and revenue of -- for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.